Mohamed Salah

5PUBLICATIONS
10CO-AUTHORS
Autonomic nervous systemClinical pharmacology and therapeuticsMolecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 19, 2025
Targeting Neutrophil-Mediated Inflammation: Identification of Pyrazolidinone Carboxamide Derivatives as Potent Selective Inhibitors of Formyl Peptide Receptor 1 (FPR1)-Activated Neutrophils.

Mohammad Abdel-Halim, Reem A Wagdy, Mohamed Salah

|Jun 27, 2023
Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model.

Mohamed Salah, Mariam Tahoun, Jeannette Rudzitis-Auth

|Jul 26, 2019
Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of Osteoporosis.

Ahmed S Abdelsamie, Mohamed Salah, Lorenz Siebenbürger

|Jan 16, 2019
Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing.

Ahmed S Abdelsamie, Steven Herath, Yannik Biskupek

|Aug 16, 2018
Design and synthesis of conformationally constraint Dyrk1A inhibitors by creating an intramolecular H-bond involving a benzothiazole core.

Mohamed Salah, Mohammad Abdel-Halim, Matthias Engel

Pageof 1

Frequent Collaborators

3 joint publications

Ahmed S Abdelsamie

3 joint publications

Martin Frotscher

3 joint publications

Chris J van Koppen

2 joint publications

Mohammad Abdel-Halim